(Q37636173)

21 August 2017

1 reference

title

Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

21 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

systemic inflammation

1 reference

Sabina A Antoniu

1

1 reference

21 August 2017

1 March 2010

1 reference

21 August 2017

1 reference

21 August 2017

15

1 reference

21 August 2017

2

1 reference

21 August 2017

97-103

1 reference

Inhaled therapy for stable chronic obstructive pulmonary disease

21 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Role for interleukin-6 in COPD-related pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

C-reactive protein levels and survival in patients with moderate to very severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Long-acting inhaled beta 2-agonists for stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Associations of IL6 polymorphisms with lung function decline and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Inflammatory markers and longitudinal lung function decline in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

New concepts in the pathobiology of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Role of TNFalpha in pulmonary pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

C-reactive protein in patients with COPD, control smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13547500903311902

10.3109/13547500903311902

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19929747